Navigation Links
Crdentia's VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
Date:9/11/2007

DALLAS, Sept. 11 /PRNewswire-FirstCall/ -- Crdentia Corp. (OTC Bulletin Board: CRDT), a leading healthcare staffing company, today announced that AudioStocks.com has posted an exclusive interview with Crdentia's Vice President of Marketing, Christina Hogan, on the Audiostocks.com website.

In the interview, Ms. Hogan discusses Crdentia's national marketing initiatives, brand positioning and plans for short-term and long-term strategic growth. In addition, the interview discusses market trends and how they favor the healthcare staffing industry.

The complete audio interview with Ms. Hogan can be found exclusively at http://www.audiostocks.com.

About Crdentia Corp.

Crdentia Corp., one of the nation's leading providers of healthcare staffing solutions, is focused on recruiting talented national and international healthcare professionals to meet the ever-increasing employment needs of over 1,500 clients. Crdentia is one of the few companies that can provide quality temporary staff for all healthcare industry positions including local nurses, travel nurses, allied health and locum tenens professionals. For more information, visit http://www.crdentia.com.

About AudioStocks.com

AudioStocks.com is an Internet-based publishing platform designed to create, catalogue, distribute and make functional, financial content and data related to that content. AudioStocks.com software is primarily used to: (1) facilitate executive and company participation in industry and event-based roundtables and conferences; (2) create and distribute audio-based content related to a particular private or public company or an industry in which a company conducts business; (3) append interview-related and other content to traditional press releases; and (4) for registered investment professionals only, to add interview-based audio content to financial res
'/>"/>

SOURCE Crdentia Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Christina Aguileras Silence Fuels Pregnancy Rumours
2. Protein provides antioxidant protection to Neurons
3. Acupuncture provides relief
4. Micro-camera provides new breast imaging technique
5. Hormone therapy provides no heart benefit
6. MicroRNA provides new insight into birth defects
7. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
8. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
9. Cholesterol provides immunity against infection by certain parasites
10. John Hopkins CGHH program provides Global Health education
11. London Hospital Provides Specialized Care For Pregnant Women

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...short to draw definite conclusions, experts say, ...-- In diabetic patients with blocked coronary arte...s at one year whether patients undergo bypass surg...ers report. , Bypass surgery has been the stand...artery disease. However, less invasive approaches ...
(Date:11/25/2009)...others to overlook needed care, study finds , ...other,s depression can worsen her child,s asthma, ...study of 262 black mothers and their children foun...symptoms had more frequent asthma symptoms, while ... had less frequent asthma symptoms. , The Johns...
(Date:11/25/2009)...- MISSIONSkincare ®isproudtosupportGNC,seffor...annualSt.Jude ThanksandGiving campaign,$1fromthepu...(TM)LipBalm willbedonatedtoSt.Jude.Additionally,GN...ionatcheckoutatoneoftheir5,000+retaillocationsorat...duringtheir2009 ThanksandGiving campaign. ,, "W...
(Date:11/25/2009)...ine carried into the body on a carefully engineere...sfully eliminate tumors in mammals, scientists rep...l Medicine . , The new approach, pioneered by bi..., uses plastic disks impregnated with tumor-specif...ram the mammalian immune system to attack tumors. ...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
..., SWITZERLAND, March 13 /PRNewswire-FirstCall/ - N...olly-owned subsidiary of Neurochem,Inc. (NASDAQ: ...king new,initiatives to pursue the drug developmen...s. Neurochem,s decision to build,upon its eprodisa...
...y Outlines Milestones for 2008 -, EMERYVILLE, Cal...y announced financial results for the fourth quart... Quarter Results, The company reported revenues f...riod in 2006, is due primarily,to the recognition ...
... results of combination therapy VELCADE, melphalan...mission rate with 85 percent of patients ... Mass., March 13 Millennium,Pharmaceuticals, Inc....d prednisone (VcMP) in newly diagnosed multiple,my...
...ntone Hosts Fundraiser, NEW YORK, March 13 DKMS ...awford at their "Linked Against Leukemia Gala" on,...ity. The 2nd annual,black-tie affair is a benefit ...te more than 13,000 transplants., The evening wil...
...ured majority of convertible notes due June 2008 ...orward Projects Zevalin(R) net sales revenues ...e-Cell Therapeutics,Inc. (CTI) (Nasdaq: CTIC ; MT...ompletion of Zevalin(R) (Ibritumomab Tiuxetan) acq...
...UVER Shining synchrotron light on environmental q... a Memorandum of Understanding (MOU) signed today ...Light Source (CLS) and MIRARCO Mining Innovation. ...his collaboration will undoubtedly be of tremendou...
Other Medicine News:Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 2Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 3Health News:Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis 4Health News:Bionovo Announces 2007 Financial Results and Highlights 2Health News:Bionovo Announces 2007 Financial Results and Highlights 3Health News:Bionovo Announces 2007 Financial Results and Highlights 4Health News:Bionovo Announces 2007 Financial Results and Highlights 5Health News:Bionovo Announces 2007 Financial Results and Highlights 6Health News:Bionovo Announces 2007 Financial Results and Highlights 7Health News:Bionovo Announces 2007 Financial Results and Highlights 8Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 2Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 3Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 4Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 5Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 6Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 7Health News:Super Model Cindy Crawford will be Honored at DKMS 'Linked Against Leukemia Gala' on May 7th at Capitale 2Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 2Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 3Health News:Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results 4Health News:MIRARCO, Canadian Light Source agreement lights way to greener mining 2
(Date:11/25/2009)...rdingtoMillenniumResearchGroup(MRG),theglobalautho...y$3billionUSmarketfortraumafixationdeviceswillcont...recenteconomicslowdown.MRG,s USMarketsforTraumaDev...lydynamicoverthenextfiveyears,withcompetitorsintro...mentsofthetraumafixationmarket,fuelingmarketgrowth...
(Date:11/25/2009)...er.comannouncesthatanewmarketresearchreportisavail...USMarketTrends&Analysis http://www.reportlink...et-Trends--Analysis.html ,, TheUSintranasaldru...capplicationsfromthedeliveryofconventionallocalthe...gs.Thefutureofthetechnologyhingesontotheeffectivee...
(Date:11/24/2009)...ChindexInternational,Inc.,("Chindex")(Nasdaq: CHDX...althcareproductsandservicesinthePeople,sRepublicof...stAnnualPiperJaffray,"Unplugged"HealthCareConferen...el. , Managementiscurrentlyscheduledtopresent...-onemeetingsthroughouttheday.Awebcast,ofthepresent...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Prism and Medical College of Wisconsin investigators receive 241 6 million NIH grant to develop advanced medical imaging tools 61424 1Prism and Medical College of Wisconsin investigators receive 241 6 million NIH grant to develop advanced medical imaging tools 61424 2Prism and Medical College of Wisconsin investigators receive 241 6 million NIH grant to develop advanced medical imaging tools 61424 3Shire announces publication of open label study on coadministration of INTUNIV with stimulants 61419 1Shire announces publication of open label study on coadministration of INTUNIV with stimulants 61419 2Shire announces publication of open label study on coadministration of INTUNIV with stimulants 61419 3Study shows link between influenza virus and fever 10734 1Study shows link between influenza virus and fever 10734 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: